Global Isoxsuprine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Isoxsuprine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Isoxsuprine (used as isoxsuprine hydrochloride) is a drug used as a vasodilator in humans (under the trade name Duvadilan) and equines. Isoxsuprine is a β2 adrenoreceptor agonist that causes direct relaxation of uterine and vascular smooth muscle via β2 receptors.
Isoxsuprine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Isoxsuprine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Peripheral Vasodilator and β-Sympathomimetic Agent are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Isoxsuprine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Isoxsuprine key manufacturers include Pharco, Invision Pharma, Zenon Healthcare, Systemic, Wockhardt, Solvay Pharma, Glenmark, Bristol-Myers Squibb and Merck Sharp and Dohme, etc. Pharco, Invision Pharma, Zenon Healthcare are top 3 players and held % sales share in total in 2022.
Isoxsuprine can be divided into Use in Humans and Use in Animals, etc. Use in Humans is the mainstream product in the market, accounting for % sales share globally in 2022.
Isoxsuprine is widely used in various fields, such as Peripheral Vasodilator and β-Sympathomimetic Agent, etc. Peripheral Vasodilator provides greatest supports to the Isoxsuprine industry development. In 2022, global % sales of Isoxsuprine went into Peripheral Vasodilator filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Isoxsuprine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Pharco
Invision Pharma
Zenon Healthcare
Systemic
Wockhardt
Solvay Pharma
Glenmark
Bristol-Myers Squibb
Merck Sharp and Dohme
Amriya
Pfizer
Winston Pharma
Johnson and Johnson
Aspen Pharmacare
Abbott
Drugmaker's Laboratoires
Segment by Type
Use in Humans
Use in Animals
Peripheral Vasodilator
β-Sympathomimetic Agent
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Isoxsuprine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Isoxsuprine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Isoxsuprine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Isoxsuprine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Isoxsuprine introduction, etc. Isoxsuprine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Isoxsuprine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.![](http://localhost/mraccuracy/images/About Report.webp)
Isoxsuprine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Isoxsuprine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Peripheral Vasodilator and β-Sympathomimetic Agent are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Isoxsuprine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Isoxsuprine key manufacturers include Pharco, Invision Pharma, Zenon Healthcare, Systemic, Wockhardt, Solvay Pharma, Glenmark, Bristol-Myers Squibb and Merck Sharp and Dohme, etc. Pharco, Invision Pharma, Zenon Healthcare are top 3 players and held % sales share in total in 2022.
Isoxsuprine can be divided into Use in Humans and Use in Animals, etc. Use in Humans is the mainstream product in the market, accounting for % sales share globally in 2022.
Isoxsuprine is widely used in various fields, such as Peripheral Vasodilator and β-Sympathomimetic Agent, etc. Peripheral Vasodilator provides greatest supports to the Isoxsuprine industry development. In 2022, global % sales of Isoxsuprine went into Peripheral Vasodilator filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Isoxsuprine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Pharco
Invision Pharma
Zenon Healthcare
Systemic
Wockhardt
Solvay Pharma
Glenmark
Bristol-Myers Squibb
Merck Sharp and Dohme
Amriya
Pfizer
Winston Pharma
Johnson and Johnson
Aspen Pharmacare
Abbott
Drugmaker's Laboratoires
Segment by Type
Use in Humans
Use in Animals
Segment by Application
Peripheral Vasodilator
β-Sympathomimetic Agent
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Isoxsuprine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Isoxsuprine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Isoxsuprine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Isoxsuprine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Isoxsuprine introduction, etc. Isoxsuprine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Isoxsuprine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
![](http://localhost/mraccuracy/images/About Report.webp)